Scottish cell signalling unit forging links with industry
29 December 2009
Ian Schofield
Please Login to read the full article.
29 December 2009
Ian Schofield
ian.schofield@informa.com
The Scottish Institute for Cell Signalling (SCILLS) at the University of Dundee says its new unit for research into ubiquitylation, the body's mechanism for controlling cell activity, is attracting strong interest from the pharmaceutical industry. The research is expected to lead to the development...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
- Aveo signs BI to manufacture PhII candidate ficlatuzumab
- CHMP positive opinions for AstraZeneca, Merck KGaA, Roche, Alcon and Merck-Serono
- Pfizer surrenders neratinib to Puma which raises $55m for new development plan
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
